EU-GMP INSPECTION, 2013

On 19 March 2013, the third EU-GMP Inspection was conducted in five continuous days at STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “Company” or “Factory II“), located at Vietnam – Singapore Industrial Park, Binh Duong and the Factory II was recognized as a pharma facility complying with European Good Manufacturing Practice issued by European Medicines Agency, Germany (the “EMA“).

Since 6 years from the date the Factory II has been officially run the operation, the Factory II has continuously recognized as European standard pharmaceutical facility. This is the collective pride of its company’s employees and this proves that we maintain product quality inherent.

It was really a pleasure for us to maintain and observe the right to export the products to foreign markets such as Europe, England, Australia, etc. and some countries complying PIC Convention (Pharmaceutical Inspection Convention).

With this achievement, the company will  be increasingly relentless determination to improve our infrastructure, and investment in machinery, equipment, technology, and qualified personnel as well, etc. to produce and provide high-quality products for the domestic and export activities.

About STELLA

STELLAPHARM is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, anti-viral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.

The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.

Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An Town, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: info@stellapharm.com | W: www.stellapharm.com

You May like

05 Sep 2024

VIỆT NAM’S PHARMACEUTICAL INDUSTRY FACES MANY CHALLENGES

Việt Nam’s pharmaceutical industry still faces many challenges and difficulties in the context of increasingly deep integration with the world, participants heard at a special seminar in Hà Nội. HÀ NỘI — Việt Nam’s pharmaceutical industry still faces many challenges and difficulties in the context of increasingly deep integration with the world, participants heard at

15 Aug 2024

KHU CÔNG NGHIỆP DƯỢC – SINH HỌC ĐẦU TIÊN Ở VIỆT NAM

Tỉnh Thái Bình, thuộc miền Bắc Việt Nam, dự định xây dựng một khu công nghiệp để phát triển sản phẩm dược phẩm và sinh học, đánh dấu sự ra đời của khu công nghiệp đầu tiên theo loại hình này ở Việt Nam. Các đối tác trong dự án bao gồm Makara Capital Partners